Estrogen Receptor α Mediates Breast Cancer Cell Resistance to Paclitaxel through Inhibition of Apoptotic Cell Death

Overview of attention for article published in Cancer Research, June 2007

Altmetric Badge

Mentioned by

patent: 28 patents

Readers on

mendeley: 47 Mendeley
citeulike: 2 CiteULike

So far, Altmetric has seen 28 patents that reference this research output.

Concomitant administration of glucocorticoid receptor modulator relacorilant and…

Grant US-12589094-B2

United States of America

31 Mar 2026

Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused azadecalin…

Grant US-12514849-B2

United States of America

06 Jan 2026

Treatments for amyotrophic lateral sclerosis using dazucorilant

Grant US-12433882-B2

United States of America

07 Oct 2025

Formulations of dazucorilant, a glucocorticoid receptor modulator

Grant US-12370188-B2

United States of America

29 Jul 2025

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 24 additional patents.